0001140361-13-044973.txt : 20131204
0001140361-13-044973.hdr.sgml : 20131204
20131204191801
ACCESSION NUMBER: 0001140361-13-044973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131202
FILED AS OF DATE: 20131204
DATE AS OF CHANGE: 20131204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIMICK NEIL F
CENTRAL INDEX KEY: 0001248380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 131258480
MAIL ADDRESS:
STREET 1: 25913 RICH SPRINGS CIRCLE
STREET 2: C/O WEBMD CORP
CITY: LA GUNS HILLS
STATE: CA
ZIP: 92653
FORMER NAME:
FORMER CONFORMED NAME: DIMICK NEIL F
DATE OF NAME CHANGE: 20030626
4
1
doc1.xml
FORM 4
X0306
4
2013-12-02
0
0000069499
MYLAN INC.
MYL
0001248380
DIMICK NEIL F
1500 CORPORATE DRIVE
CANONSBURG
PA
15317
1
0
0
0
Common Stock
2013-12-02
4
M
0
14286
13.43
A
46422
D
Common Stock
2013-12-02
4
S
0
14286
44.3042
D
32136
D
Stock Option Right to Buy
13.43
2013-12-02
4
M
0
14286
0
D
2010-05-07
2019-05-07
Common Stock
14286
0
D
Represents the weighted average price of the reporting person's disposition of 14,286 shares in transactions ranging from $44.22 to $44.33.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated December 12, 2012.
/s/ Neil F. Dimick
2013-12-04